β-interferon regulates the immunomodulatory activity of neonatal rodent microglia

Journal of Neuroimmunology

Volumn 72, Issue 1, 1997, Pages 11-19

  Hall, G L ^a,b   Wing, M G ^c   Compston, D A S ^a,b   Scolding, N J ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

beta interferon; microglia; multiple sclerosis; rodent

Indexed keywords

RECOMBINANT BETA INTERFERON; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; GLIA CELL; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY BURST;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANIMALS, NEWBORN; ANTINEOPLASTIC AGENTS; CELL DIVISION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERFERON-BETA; MICROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, FC; RESPIRATORY BURST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031012848     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00128-2     Document Type: Article

References (42)

1. The IFN-β multiple sclerosis study group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43, 655-661.
2. Paty, D. W., Li, D. K. B., The UBC MS/MRI study group, the IFN-β multiple sclerosis study group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II MRI analysis results of a multicenter randomized, double-blind, placebo-controlled trial. Neurology 43, 662-667.
3. Moore, R. N., Larsen, H.S., Horohoo, D.W. and Rouse, B.T. (1984) Endogenous regulation of macrophage proliferative expansion by colony stimulating factor-induced Interferon. Science 223, 178.
4. Lin, S. L., Pledger, J. and Tamm, I. (1986) Interferon effects on PDGF action. In: W.E. Stewart and H. Schellekens (Eds.), The biology for the interferon system. Elsevier, New York, p. 311.
5. Ortaldo, J. R. and Herberman, R.B. (1986) Augmentation of natural killer activity. In: F. Boca Raton (Ed.), Immunobiology of natural killer cells, Vol. 2, CRC Press, p. 145.
6. Lindahl, P., Leary, P. and Gresser, I. (1972) Enhancement by Interferon of the specific toxicity of sensitized lymphocytes. Proc. Natl. Acad. Sci. USA 69, 721.
7. Chen, B. D.-M. and Najor, F. (1987) Macrophage activation by interferon α and β is associated with a loss of proliferative capacity. Cell Immunol. 106, 343-354.
8. Vogel, S. N., Finbloom, D.S., English, K.E., Rosenstreich, D.L. and Langreth, S.G. (1982) Interferon-induced enhancement of macrophage Fc receptor expression: β-interferon treatment of C3H/HeJ macrophages results in increased numbers and density of Fc receptors. J. Immunol. 130, 1210-1214.
9. Ling, P. D., Warren, M.K. and Vogel, S.N. (1985) Antagonistic effect of interferon-β on the interferon-γ induced expression of Ia antigen in murine macrophages. J. Immunol. 135, 1857-1863.
10. Inaba, K., Kitaura, M., Kato, T., Watanabe, Y., Kawade, Y. and Muramatsu, S. (1986) Contrasting effect of α / β-and γ-interferons on expression of macrophage Ia antigen. J. Exp. Med. 163, 1030-1035.
11. Barna, B. P., Chou, S.M., Jacobs, B., Yen-Lieberman, B. and Ransohoff, R.M. (1989) Interferon-β impairs induction of HLA-DR antigen expression in cultured human astrocytes. J. Neuroimmunol. 23, 45-53.
12. Prineas, J. W. (1985) In Handbook of Clinical Neurology, Vol. 3, Elsevier, p. 213-257.
13. Linington, C., Berger, T., Perry, L., Weerth, S., Hinze-Selch, D., Zhang, Y., Lu, H.-C., Lassmann, H. and Wekerle (1993) T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23, 1364-1372.
14. Raine, C. S. (1991) Multiple sclerosis: a pivital role for the T cell in lesion development. Neuropathol. and Appl. Neurobiol. 17, 265-274.
15. Woodroofe, M. N., Hayes, G.M. and Cuzner, M.L. (1989) Fc receptor density, MHC antigen expression and superoxide production are increased in interferon-γ-treated microglia isolated from adult rat brain. Immunology 68, 421-426.
16. Williams, K., Bar-Or, A., Ulvestad, E., Olivier, A., Antel, J.P. and Yong, V.W. (1992) Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J. Neuropath. Exp. Neurol. 51, 538-549.
17. Williams, K., Ulvestad, E., Cragg, L., Blain, M. and Antel, J.P. (1993) Induction of primary T cell responses by human glial cells. J. Neurosci. Res. 36, 382-390.
18. Cash, E., Zhan, Y. and Rott, O. (1993) Microglia present myelin antigens to T cells after phagocytosis of oligodendrocytes. Cellular Immunology 147, 129-138.
19. Williams, K., Ulvestad, E. and Antel, J.P. (1994) B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur. S. Immunol. 24, 3031-3037.
20. Zajicek, J.P., Wing, M.G., Scolding, N.J. and Compston, D.A.S. (1992) Interactions between oligodendrocytes and microglia. Brain 115, 1611-1631.
21. Giulian, D. and Baker, T.J. (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6, 2163-2178.
22. Stewart, J., Glass, E.J., Weir, D.M. and Daha, M.R. (1986) Macrophage membrane receptors. In: D.M. Weir (Ed.), Handbook of Experimental Immunology: Cellular Immunology. Blackwell.
23. + T lymphocyte clone is mediated by interferon-γ and tumour necrosis factor alone or synergistically. Clin. Exp. Immunol. 82, 208-213.
24. Lu, H.-T., Riley, J.L., Babcock, G.T., Huston, M., Stark, G.R., Boss, J.M. and Ransohoff, R.M. (1995) Interferon (IFN) β acts downstream of IFN-γ-induced class II transactivator messenger RNA accumulation to block major histocompatability complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-γ. J. Exp. Med. 182, 1517-1525.
25. Vogel, S. N., Finbloom, D.S., English, K.E., Rosenstreich, D.L. and Langreth, S.G. (1983) Interferon-induced enhancement of macrophage Fc receptor expression: β-interferon treatment of C3H/HeJ macrophages results in increased numbers and density of Fc receptors. J. Immunol. 130, 1210-1214.
26. Durum, S. K. and Oppenheim, J.J. (1993) Proinflammatory cytokines and immunity. In: W.E. Paul (Ed.), Fundamental Immunology. Raven Press, New York, pp. 801-883.
27. Garotta, G., Talmadge, K.W., Richard, J., Pink, L., Dewald, B. and Baggiolini, M. (1986) Functional antagonism between type I and type II interferons on human macrophages. Biochem. Biophys. Res. Commun. 140, 948-954.
28. Fertsch-Ruggio, D., Schoenberg, D.R. and Vogel, S.N. (1988) Induction of macrophage Ia antigen expression by rIFN-γ and down regulation by IFN-α/β and dexamethasone are regulated transcriptionally. J. Immunol. 141, 1582-1589.
29. Ransohoff, R. M., Devajyothi, C., Estes, M.L., Babcock, G., Rudick, R.A., Frohman, E.M. and Barna, B.P. (1991) Interferon-β specifically inhibits interferon-γ-induced class II major histocompatability complex gene transcription in a human astrocytoma cell line. J. Neuroimmunol. 33, 103-112.
30. Hall, G. L., J. Girdlestone, M. G. Wing, N. J. Scolding, and D. A. S. Compston. (1996). Beta interferon inhibits gamma interferon-induced major histocompatability complex class II expression on neonatal rodent microglia through a post-translational block of class II intracellular transport. submitted.
31. Testa, U., L. Conti, N. M. Sposi, B. Varano, E. Tritarelli, W. Malorni, P. Samoggia, G. Rainaldi, C. Pelschle, F. Belardelli, and S. Gessani. (1995). IFN-β selectively down-regulates transferrin receptor expression in human peripheral blood macrophages by a post-translational mechanism. J. Immunol. 115:427-435.
32. Hofman, F. M., Hinton, D.R., Johnson, J. and Merill, J.E. (1990) Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170, 607-612.
33. Selmaj, K. W. and Raine, C.S. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346.
34. Howard, M. C., Miyajimi, A. and Coffman, R. (1993) T-cell-derived cytokines and their receptors. In: P.W.E. (Ed.), Fundamental Immunology, Raven Press, New York, pp. 763-800.
35. Traugott, U. and Lebon, P. (1988) Demonstration of α, β, and γ-interferon inactive chronic multiple sclerosis lesions. Ann. N.Y. Acad. Sci. 540, 309-311.
36. Panitch, H. S., Hirsch, R.L., Schindler, J. and Johnson, K.P. (1987) Treatment of multiple sclerosis with γ-inteferon: exacerbations associated with activation of the immune system. Neurology 37, 1097-1102.
37. Rudge, P., Miller, D., Crimlisk, H. and Thorpe, J. (1995) Does interferon beta cause initial exacerbations of multiple sclerosis? The Lancet 345, 580.
38. Rudick, R. A., Carpenter, C.S., Cookfair, D.L., Tuohy, V.K. and Ransohoff, R.M. (1993) In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta. Neurology 43, 2080-2087.
39. Noronha, A., Toscas, A. and Jensen, M.A. (1993) Interferon β decreases T cell activation and interferon γ production in multiple sclerosis. J. Neuroimmunol. 46, 145-154.
40. Noronha, A., Toscas, A. and Jensen, M.A. (1990) Interferon beta augments suppressor cell function in multiple sclerosis. Annals of Neurology 27, 207-210.
41. Noronha, A., Toscas, A. and Jensen, M.A. (1992) Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor cell functions in multiple sclerosis. Annals of Neurology 31, 103-106.
42. Shakir, S., Byskosh, P.V. and Reder, A.T. (1994) Interferon-β induces interleukin-10 mRNA in mononuclear cells (MNC). Neurology 44, A211.